Literature DB >> 12960542

Urgent adenotonsillectomy: an analysis of risk factors associated with postoperative respiratory morbidity.

Karen A Brown1, Isabelle Morin, Chantal Hickey, John J Manoukian, Gillian M Nixon, Robert T Brouillette.   

Abstract

BACKGROUND: The aim of this study was to determine the frequency and type of respiratory complications after urgent adenotonsillectomy (study group) for comparison with a control group of children undergoing a sleep study and adenotonsillectomy for obstructive sleep apnea syndrome. A second aim was to assess risk factors predictive of respiratory complications after urgent adenotonsillectomy.
METHODS: The perioperative course of children who underwent adenotonsillectomy between January 1, 1999, and March 31, 2001, was reviewed. Two groups of children were identified from two different databases: the hospital database for surgical procedures (the study group) and the sleep laboratory database (the control group). The retrospective chart review focused on the preoperative status (including an evaluation for obstructive sleep apnea), anesthetic management, and need for postoperative respiratory interventions.
RESULTS: A total of 64 consecutive cases for urgent adenotonsillectomy were identified, and 54 children met the inclusion criteria. Thirty-three children (60%) had postoperative respiratory complications necessitating a medical intervention; 11 (20.3%) required a major intervention (reintubation, ventilation, and/or administration of racemic epinephrine or Ventolin), and 22 (40.7%) required a minor intervention (oxygen administration). Six children (11.1%) required reintubation in the recovery room for respiratory compromise. Risk factors for respiratory complications were an associated medical condition (odds ratio, 8.15; 95% confidence interval, 1.81-36.73) and a preoperative saturation nadir less than 80% (odds ratio, 5.54; 95% confidence interval, 1.15-26.72). Sixteen (49%) of the medical interventions were required within the first postoperative hour. Atropine administration, at induction, decreased the risk of postoperative respiratory complications (odds ratio, 0.18; 95% confidence interval, 0.11-1.050. CONTROL GROUP: Of 75 children who underwent a sleep study and adenotonsillectomy, 44 had sleep apnea and were admitted to hospital after elective adenotonsillectomy. Sixteen (36.4%) children had postoperative respiratory complications necessitating a medical intervention. Six percent of the children (n = 3) required a major medical intervention. No child required reintubation for respiratory compromise.
CONCLUSIONS: Severe obstructive sleep apnea syndrome and an associated medical condition are risk factors for postadenotonsillectomy respiratory complications. Risk reductions strategies should focus on their assessment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960542     DOI: 10.1097/00000542-200309000-00013

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  13 in total

1.  Childhood obstructive sleep apnoea: anaesthetic implications for adenotonsillectomy are important.

Authors:  David R Ball; Paul Jefferson
Journal:  BMJ       Date:  2005-08-13

2.  Screening for Pediatric Obstructive Sleep Apnea before Ambulatory Surgery.

Authors:  Stacey L Ishman; Kareem O Tawfik; David F Smith; Kristin Cheung; Lauren M Pringle; Matthew J Stephen; Tiffany L Everett; Tracey L Stierer
Journal:  J Clin Sleep Med       Date:  2015-07-15       Impact factor: 4.062

Review 3.  Respiratory Protective Equipment for Healthcare Providers During Coronavirus Pandemic: "Nec Temere, Nec Timide".

Authors:  H Bengü Çobanoğlu; Görkem Eskiizmir; Mustafa Kürşat Gökcan
Journal:  Turk Arch Otorhinolaryngol       Date:  2020-12-01

4.  Are nocturnal hypoxemia and hypercapnia associated with desaturation immediately after adenotonsillectomy?

Authors:  Nicholas M Dalesio; Douglas H McMichael; James R Benke; Sean Owens; Kathryn A Carson; Deborah A Schwengel; Alan R Schwartz; Stacey L Ishman
Journal:  Paediatr Anaesth       Date:  2015-04-09       Impact factor: 2.556

Review 5.  Executive summary of respiratory indications for polysomnography in children: an evidence-based review.

Authors:  Merrill S Wise; Cynthia D Nichols; Madeleine M Grigg-Damberger; Carole L Marcus; Manisha B Witmans; Valerie G Kirk; Lynn A D'Andrea; Timothy F Hoban
Journal:  Sleep       Date:  2011-03-01       Impact factor: 5.849

6.  Practice parameters for the respiratory indications for polysomnography in children.

Authors:  R Nisha Aurora; Rochelle S Zak; Anoop Karippot; Carin I Lamm; Timothy I Morgenthaler; Sanford H Auerbach; Sabin R Bista; Kenneth R Casey; Susmita Chowdhuri; David A Kristo; Kannan Ramar
Journal:  Sleep       Date:  2011-03-01       Impact factor: 5.849

7.  Apnea and oxygen desaturations in children treated with opioids after adenotonsillectomy for obstructive sleep apnea syndrome: a prospective pilot study.

Authors:  Justin D Khetani; Parvaz Madadi; Doron D Sommer; Desigen Reddy; Johanna Sistonen; Colin J D Ross; Bruce C Carleton; Michael R Hayden; Gideon Koren
Journal:  Paediatr Drugs       Date:  2012-12-01       Impact factor: 3.022

8.  Effect of Albuterol Premedication vs Placebo on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies: The REACT Randomized Clinical Trial.

Authors:  Britta S von Ungern-Sternberg; David Sommerfield; Lliana Slevin; Thomas F E Drake-Brockman; Guicheng Zhang; Graham L Hall
Journal:  JAMA Pediatr       Date:  2019-06-01       Impact factor: 16.193

9.  The utility of a portable sleep monitor to diagnose sleep-disordered breathing in a pediatric population.

Authors:  Colin Massicotte; Suhail Al-Saleh; Manisha Witmans; Indra Narang
Journal:  Can Respir J       Date:  2013-09-30       Impact factor: 2.409

10.  Polysomnography parameters as predictors of respiratory adverse events following adenotonsillectomy in children.

Authors:  Lena Xiao; Nicholas Barrowman; Franco Momoli; Kimmo Murto; Matthew Bromwich; Frédéric Proulx; Sherri L Katz
Journal:  J Clin Sleep Med       Date:  2021-11-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.